Hepatobiliary Surgery and Nutrition-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2025-03-19 ms5000002977722152 来自上海

影响因子为8.0，属于中科院Q1区，JCR Q1区
适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。
平均审稿速度较快，一般在2-3个月左右。
年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。

24 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2025-03-19 ms2000000994891205 来自湖北省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科;临床研究
经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上

27 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2024-12-20 94752114 来自山东省

请问这个杂志，版面费免费吗/审稿费免费吗

30 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2024-08-22 ms5000000711521518 来自新疆

first decision多久啊

68 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2022-05-11 ms8000001954244823

投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊

155 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2023-12-19 ms2000000991085016 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！

132 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2023-05-24 sur_wu 来自上海

有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事

174 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2023-05-24 sur_wu 来自上海

有人知道为什么文章见刊后在pubmed上检索不到是怎么回事

147 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2021-01-19 ms7000000793778495

请问这个杂志的in review是在编辑手里还是送外审？

206 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256817, encodeId=3dcb225681e94, content=影响因子为8.0，属于中科院Q1区，JCR Q1区 适合肝胆胰外科、营养学、胃肠肝病学等领域学者。收录文章类型包括原创文章、评论、社论、临床观点、图像、病例报告等。 平均审稿速度较快，一般在2-3个月左右。 年发文量较低，中国作者发文占比约20.4%，期刊对国人投稿持开放态度。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722152, createdTime=Wed Mar 19 23:31:04 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2256753, encodeId=4f822256e53d8, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;临床研究 经验分享：一年6期，每一期就三篇论著，一年18篇，论著非常难，要求高创新性和大样本，尤其是今年要涨到10分以上, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1bd15553298, createdName=ms2000000994891205, createdTime=Wed Mar 19 14:14:55 CST 2025, time=2025-03-19, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2243646, encodeId=a29b224364646, content=请问这个杂志，版面费免费吗/审稿费免费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de462959502, createdName=94752114, createdTime=Fri Dec 20 00:26:22 CST 2024, time=2024-12-20, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2221946, encodeId=25a522219461b, content=first decision多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbf19205382, createdName=ms5000000711521518, createdTime=Thu Aug 22 17:09:33 CST 2024, time=2024-08-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1218841, encodeId=5c1e121884106, content=投了两个星期了，还是in review且没有任何审稿人信息，这是什么情况啊？好中吗？千万别搞好几个月然后拒了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9aa5420274, createdName=ms8000001954244823, createdTime=Wed May 11 20:30:00 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2175747, encodeId=262821e5747d4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投了一篇回顾性研究，自认为做的还可以，但是编辑一个月后拒了。这本杂志目前综述类、共识类文章发的偏多，在提振影响因子吧。论述类开始喜欢前瞻性研究了。五年后有望跻身一区！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1376478028, createdName=ms2000000991085016, createdTime=Tue Dec 19 09:50:46 CST 2023, time=2023-12-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2138798, encodeId=0a8a2138e98bf, content=有谁知道为什么文章见刊但在Pubmed检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:59:12 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138797, encodeId=07eb2138e9714, content=有人知道为什么文章见刊后在pubmed上检索不到是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/55fdd2926f3844a58e02901f47326051/cd164ae797d549e8b5cdc9ed790bc1b5.jpg, createdBy=59502040784, createdName=sur_wu, createdTime=Wed May 24 12:58:30 CST 2023, time=2023-05-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=917959, encodeId=543991e95990, content=请问这个杂志的in review是在编辑手里还是送外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1565451544, createdName=ms7000000793778495, createdTime=Tue Jan 19 09:15:18 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071554, encodeId=6aaf10e1554e0, content=中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e742061065, createdName=dr大王, createdTime=Thu Nov 18 21:36:45 CST 2021, time=2021-11-18, status=1, ipAttribution=)]

2021-11-18 dr大王

中了一篇，从gut一路转投过来的，把gut审稿意见附件cover letter里的，编辑直接给走了个绿色通道，不到一个月就接收了，算投过的7+杂志里很快的了，感觉编辑对从权威期刊审过的稿子很感兴趣，希望明年分数继续长

183 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务